Viawealth LLC decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 1.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,242 shares of the healthcare conglomerate’s stock after selling 136 shares during the period. UnitedHealth Group comprises about 2.2% of Viawealth LLC’s investment portfolio, making the stock its 10th biggest position. Viawealth LLC’s holdings in UnitedHealth Group were worth $3,664,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently made changes to their positions in the stock. Howard Capital Management Group LLC bought a new position in shares of UnitedHealth Group during the 3rd quarter valued at $341,000. Principal Financial Group Inc. grew its holdings in shares of UnitedHealth Group by 11.3% during the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after purchasing an additional 180,479 shares during the last quarter. BIP Wealth LLC grew its holdings in shares of UnitedHealth Group by 51.0% during the 3rd quarter. BIP Wealth LLC now owns 610 shares of the healthcare conglomerate’s stock valued at $357,000 after purchasing an additional 206 shares during the last quarter. Segall Bryant & Hamill LLC grew its holdings in shares of UnitedHealth Group by 53.3% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 87,219 shares of the healthcare conglomerate’s stock valued at $50,995,000 after purchasing an additional 30,340 shares during the last quarter. Finally, Strategy Asset Managers LLC grew its holdings in shares of UnitedHealth Group by 269.2% during the 3rd quarter. Strategy Asset Managers LLC now owns 9,755 shares of the healthcare conglomerate’s stock valued at $5,703,000 after purchasing an additional 7,113 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.
Insider Transactions at UnitedHealth Group
In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 0.33% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Analysis on UnitedHealth Group
UnitedHealth Group Trading Down 0.1 %
Shares of NYSE UNH opened at $503.05 on Thursday. The stock has a market cap of $460.14 billion, a P/E ratio of 32.45, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a 50-day moving average of $510.48 and a 200 day moving average of $548.22.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same period last year, the business earned $5.83 EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.67%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- What Investors Need to Know to Beat the Market
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Alphabet’s Officially In A Bear Market—Time To Buy?
- The How And Why of Investing in Oil Stocks
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.